GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas.

The Kentucky company has continued its return from bankruptcy by acquiring CBD Capital, a provider of CBD distillate, isolate and water-soluble bulk ingredients as well as white and private label services to the UK, the EU and markets worldwide.

It follows the earlier acquisition of UK-based Taylor Mammon, another major player in the same field.

Read full article
I'm already a subscriber

Freddie Dawson

Managing editor, news
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization